ARPE-19 CELL LINE
UNII DNW3UM8W8R

Substance Identification & Data

This profile provides standardized clinical and technical data for Arpe-19 Cell Line, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DNW3UM8W8R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DNW3UM8W8R
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ARPE-19 CELL LINE
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Arpe-19 Cell Line. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ARPE-19
ARPE-19 (RETINAL PIGMENT EPITHELIUM CELL LINE WITH A DELETION IN THE LONG ARM OF CHROMOSOME 9 AND AN ADDITION IN THE LONG ARM OF CHROMOSOME 19)
ARPE-19 (SPONTANEOUSLY ARISING RETINAL PIGMENT EPITHELIA (RPE) CELL LINE DERIVED IN 1986 BY AMY AOTAKI-KEEN FROM THE NORMAL EYES OF A 19-YEAR-OLD MALE)
ARPE-19 CELL LINE

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record